Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kirkpatrick

Showing results (261-270 of 283) with videos related to

Pageof 29
Sort By:
The Medical Journal of Australia|February 13, 2021
Reducing Medical Admissions and Presentations Into Hospital through Optimising Medicines (REMAIN HOME): a stepped wedge, cluster randomised controlled trialChristopher R Freeman, Ian A Scott, Karla Hemming, et al.
Clinical Pharmacology and Therapeutics|February 7, 2021
Evaluation of Meropenem-Ciprofloxacin Combination Dosage Regimens for the Pharmacokinetics of Critically Ill Patients With Augmented Renal ClearanceAkosua A Agyeman, Kate E Rogers, Jessica R Tait, et al.
Biorxiv : the Preprint Server for Biology|June 29, 2026
Rapid Identification of Infections Directly from Isolates and Clinical Specimens with the MasSpec Pen TechnologyManoj Kushwaha, Faith E Jackobs, Jacob I Mardick, et al.
Nature Communications|October 27, 2020
Mendelian randomization study of maternal influences on birthweight and future cardiometabolic risk in the HUNT cohortGunn-Helen Moen, Ben Brumpton, Cristen Willer, et al.
Clinical Pharmacokinetics|January 19, 2011
Clinical pharmacokinetics of metforminGarry G Graham, Jeroen Punt, Manit Arora, et al.
Epidemiology and Infection|February 16, 2018
Cost-utility analysis of antiviral use under pandemic influenza using a novel approach - linking pharmacology, epidemiology and heath economicsD B C Wu, N Chaiyakunapruk, C Pratoomsoot, et al.
The Journal of Infectious Diseases|September 30, 2024
Population Pharmacokinetic Modeling of Cefepime, Meropenem, and Piperacillin-Tazobactam in Patients With Cystic FibrosisStephanie L Rolsma, Andrew Sokolow, Pratish C Patel, et al.
Contemporary Clinical Trials|December 29, 2016
DIETFITS study (diet intervention examining the factors interacting with treatment success) - Study design and methodsMichael V Stanton, Jennifer L Robinson, Susan M Kirkpatrick, et al.
British Journal of Clinical Pharmacology|February 9, 2017
Interdisciplinary pharmacometrics linking oseltamivir pharmacology, influenza epidemiology and health economics to inform antiviral use in pandemicsMohamed A Kamal, Patrick F Smith, Nathorn Chaiyakunapruk, et al.
Biomedical Mass Spectrometry|April 1, 1980
Gas chromatography mass spectrometry computer analysis of volatile halogenated hydrocarbons in man and his environment--A multimedia environmental studyJ Barkley, J Bunch, J T Bursey, et al.
Pageof 29

Showing results (261-270 of 283) with videos related to

Sort By:
Pageof 29
The Medical Journal of Australia|February 13, 2021
Reducing Medical Admissions and Presentations Into Hospital through Optimising Medicines (REMAIN HOME): a stepped wedge, cluster randomised controlled trialChristopher R Freeman, Ian A Scott, Karla Hemming, et al.
Clinical Pharmacology and Therapeutics|February 7, 2021
Evaluation of Meropenem-Ciprofloxacin Combination Dosage Regimens for the Pharmacokinetics of Critically Ill Patients With Augmented Renal ClearanceAkosua A Agyeman, Kate E Rogers, Jessica R Tait, et al.
Biorxiv : the Preprint Server for Biology|June 29, 2026
Rapid Identification of Infections Directly from Isolates and Clinical Specimens with the MasSpec Pen TechnologyManoj Kushwaha, Faith E Jackobs, Jacob I Mardick, et al.
Nature Communications|October 27, 2020
Mendelian randomization study of maternal influences on birthweight and future cardiometabolic risk in the HUNT cohortGunn-Helen Moen, Ben Brumpton, Cristen Willer, et al.
Clinical Pharmacokinetics|January 19, 2011
Clinical pharmacokinetics of metforminGarry G Graham, Jeroen Punt, Manit Arora, et al.
Epidemiology and Infection|February 16, 2018
Cost-utility analysis of antiviral use under pandemic influenza using a novel approach - linking pharmacology, epidemiology and heath economicsD B C Wu, N Chaiyakunapruk, C Pratoomsoot, et al.
The Journal of Infectious Diseases|September 30, 2024
Population Pharmacokinetic Modeling of Cefepime, Meropenem, and Piperacillin-Tazobactam in Patients With Cystic FibrosisStephanie L Rolsma, Andrew Sokolow, Pratish C Patel, et al.
Contemporary Clinical Trials|December 29, 2016
DIETFITS study (diet intervention examining the factors interacting with treatment success) - Study design and methodsMichael V Stanton, Jennifer L Robinson, Susan M Kirkpatrick, et al.
British Journal of Clinical Pharmacology|February 9, 2017
Interdisciplinary pharmacometrics linking oseltamivir pharmacology, influenza epidemiology and health economics to inform antiviral use in pandemicsMohamed A Kamal, Patrick F Smith, Nathorn Chaiyakunapruk, et al.
Biomedical Mass Spectrometry|April 1, 1980
Gas chromatography mass spectrometry computer analysis of volatile halogenated hydrocarbons in man and his environment--A multimedia environmental studyJ Barkley, J Bunch, J T Bursey, et al.
Pageof 29